Graf Akcie RDUS (Radius Health Inc.). Diskuze k akciím RDUS. Aktuální informace RDUS.

Základní informace o společnosti Radius Health Inc. (Akcie RDUS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 713.36M
Hodnota podniku (EV) 807.35M
Tržby 248.667M
EBITDA -38.07
Zisk -60.23
Růst v tržbách Q/Q 3.36 %
Růst v tržbách Y/Y 24.04 %
P/E (Cena vůči ziskům) N/A
Forward P/E 0.13
EV/Sales 3.25
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 2.87
P/FCF N/A
Price/Book -5.77
Účetní hodnota na akcii -2.62
Hotovost na akcii 2.44
FCF vůči ceně -8.69 %
Počet zaměstnanců 310
Tržba na zaměstnance 802.152k
Profit margin -45.76 %
Operating margin -15.63 %
Gross margin 92.79 %
EBIT margin -14.77 %
EBITDA margin -15.31 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -63.16 %
EPS - Očekávaný růst příští rok 35.71 %
Return on assets -30.67 %
Return on equity 35.68 %
ROIC -39.55 %
ROCE -33.05 %
Dluhy/Equity -2.55
Čistý dluh/EBITDA -18.28
Current ratio 2.26
Quick Ratio 2.12
Volatilita 4.67
Beta 1.21
RSI 63.80
Cílová cena analytiků 20
Známka akcie (dle analytiků) 2.50
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 47.266M
Procento shortovaných akcií 14.64 %
Short ratio 17.45 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie RDUS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$238.645$173.317$99.239$22.112--
Cost Of Goods Sold$17.201$16.085$8.426$1.332--
Gross Profit$221.444$157.232$90.813$20.78--
Research And Development Expenses$159.712$116.757$99.911$83.076$107.406$68.28
SG&A Expenses$144.154$152.704$184.164$186.677$77.542$30.797
Other Operating Income Or Expenses--$-10.801---
Operating Expenses$321.067$285.546$303.302$271.085$184.948$99.077
Operating Income$-82.422$-112.229$-204.063$-248.973$-184.948$-99.077
Total Non-Operating Income/Expense$-26.786$-20.764$-17.274$-5.264$2.144$-2.449
Pre-Tax Income$-109.208$-132.993$-221.337$-254.237$-182.804$-101.526
Income Taxes------
Income After Taxes$-109.208$-132.993$-221.337$-254.237$-182.804$-101.526
Other Income------
Income From Continuous Operations$-109.208$-132.993$-221.337$-254.237$-182.804$-101.526
Income From Discontinued Operations------
Net Income$-109.208$-132.993$-221.337$-254.237$-182.804$-101.526
EBITDA$-62.403$-94.53$-187.786$-242.47$-183.571$-97.004
EBIT$-82.422$-112.229$-204.063$-248.973$-184.948$-99.077
Basic Shares Outstanding464645444340
Shares Outstanding464645444340
Basic EPS$-2.35$-2.89$-4.88$-5.80$-4.24$-2.56
EPS - Earnings Per Share$-2.35$-2.89$-4.88$-5.80$-4.24$-2.56
# 2020 2019 2018 2017 2016 2015
Current Ratio2.46743.31485.92375.044410.23122.6774
Long-term Debt / Capital2.07631.27580.74780.4068--
Debt/Equity Ratio-1.9291-4.62622.96550.6859--
Gross Margin92.792290.719391.509493.9761--
Operating Margin-34.5375-64.7536-205.6278-1125.963--
EBIT Margin-34.5375-64.7536-205.6278-1125.963--
EBITDA Margin-26.1489-54.5417-189.226-1096.554--
Pre-Tax Profit Margin-45.7617-76.734-223.0343-1149.769--
Net Profit Margin-45.7617-76.734-223.0343-1149.769--
Asset Turnover1.24570.79090.34580.0479--
Inventory Turnover Ratio1.8753.02181.35680.3051--
Receiveable Turnover11.75017.4425.92194.9791--
Days Sales In Receivables31.063549.045961.635873.307--
ROE - Return On Equity88.3138314.5605-365.0493-105.041-59.5108-22.0094
Return On Tangible Equity84.367272.1809-415.6563-108.7152-59.5108-22.0094
ROA - Return On Assets-57.0033-60.6856-77.1311-55.0704-53.7213-21.0432
ROI - Return On Investment-95.0536-86.7466-92.0558-62.3066-59.5108-22.0094
Book Value Per Share-2.6435-0.91531.33075.42477.120310.7316
Operating Cash Flow Per Share0.19892.72320.2043-1.4731-1.04780.5343
Free Cash Flow Per Share0.19892.72720.2538-1.4584-1.0850.5517